Cargando…
Stringent Response in Mycobacteria: From Biology to Therapeutic Potential
Mycobacterium tuberculosis is a human pathogen that can thrive inside the host immune cells for several years and cause tuberculosis. This is due to the propensity of M. tuberculosis to synthesize a sturdy cell wall, shift metabolism and growth, secrete virulence factors to manipulate host immunity,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622095/ https://www.ncbi.nlm.nih.gov/pubmed/34832573 http://dx.doi.org/10.3390/pathogens10111417 |
_version_ | 1784605613759660032 |
---|---|
author | Gupta, Kuldeepkumar Ramnaresh Arora, Gunjan Mattoo, Abid Sajid, Andaleeb |
author_facet | Gupta, Kuldeepkumar Ramnaresh Arora, Gunjan Mattoo, Abid Sajid, Andaleeb |
author_sort | Gupta, Kuldeepkumar Ramnaresh |
collection | PubMed |
description | Mycobacterium tuberculosis is a human pathogen that can thrive inside the host immune cells for several years and cause tuberculosis. This is due to the propensity of M. tuberculosis to synthesize a sturdy cell wall, shift metabolism and growth, secrete virulence factors to manipulate host immunity, and exhibit stringent response. These attributes help M. tuberculosis to manage the host response, and successfully establish and maintain an infection even under nutrient-deprived stress conditions for years. In this review, we will discuss the importance of mycobacterial stringent response under different stress conditions. The stringent response is mediated through small signaling molecules called alarmones “(pp)pGpp”. The synthesis and degradation of these alarmones in mycobacteria are mediated by Rel protein, which is both (p)ppGpp synthetase and hydrolase. Rel is important for all central dogma processes—DNA replication, transcription, and translation—in addition to regulating virulence, drug resistance, and biofilm formation. Rel also plays an important role in the latent infection of M. tuberculosis. Here, we have discussed the literature on alarmones and Rel proteins in mycobacteria and highlight that (p)ppGpp-analogs and Rel inhibitors could be designed and used as antimycobacterial compounds against M. tuberculosis and non-tuberculous mycobacterial infections. |
format | Online Article Text |
id | pubmed-8622095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86220952021-11-27 Stringent Response in Mycobacteria: From Biology to Therapeutic Potential Gupta, Kuldeepkumar Ramnaresh Arora, Gunjan Mattoo, Abid Sajid, Andaleeb Pathogens Review Mycobacterium tuberculosis is a human pathogen that can thrive inside the host immune cells for several years and cause tuberculosis. This is due to the propensity of M. tuberculosis to synthesize a sturdy cell wall, shift metabolism and growth, secrete virulence factors to manipulate host immunity, and exhibit stringent response. These attributes help M. tuberculosis to manage the host response, and successfully establish and maintain an infection even under nutrient-deprived stress conditions for years. In this review, we will discuss the importance of mycobacterial stringent response under different stress conditions. The stringent response is mediated through small signaling molecules called alarmones “(pp)pGpp”. The synthesis and degradation of these alarmones in mycobacteria are mediated by Rel protein, which is both (p)ppGpp synthetase and hydrolase. Rel is important for all central dogma processes—DNA replication, transcription, and translation—in addition to regulating virulence, drug resistance, and biofilm formation. Rel also plays an important role in the latent infection of M. tuberculosis. Here, we have discussed the literature on alarmones and Rel proteins in mycobacteria and highlight that (p)ppGpp-analogs and Rel inhibitors could be designed and used as antimycobacterial compounds against M. tuberculosis and non-tuberculous mycobacterial infections. MDPI 2021-11-01 /pmc/articles/PMC8622095/ /pubmed/34832573 http://dx.doi.org/10.3390/pathogens10111417 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gupta, Kuldeepkumar Ramnaresh Arora, Gunjan Mattoo, Abid Sajid, Andaleeb Stringent Response in Mycobacteria: From Biology to Therapeutic Potential |
title | Stringent Response in Mycobacteria: From Biology to Therapeutic Potential |
title_full | Stringent Response in Mycobacteria: From Biology to Therapeutic Potential |
title_fullStr | Stringent Response in Mycobacteria: From Biology to Therapeutic Potential |
title_full_unstemmed | Stringent Response in Mycobacteria: From Biology to Therapeutic Potential |
title_short | Stringent Response in Mycobacteria: From Biology to Therapeutic Potential |
title_sort | stringent response in mycobacteria: from biology to therapeutic potential |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622095/ https://www.ncbi.nlm.nih.gov/pubmed/34832573 http://dx.doi.org/10.3390/pathogens10111417 |
work_keys_str_mv | AT guptakuldeepkumarramnaresh stringentresponseinmycobacteriafrombiologytotherapeuticpotential AT aroragunjan stringentresponseinmycobacteriafrombiologytotherapeuticpotential AT mattooabid stringentresponseinmycobacteriafrombiologytotherapeuticpotential AT sajidandaleeb stringentresponseinmycobacteriafrombiologytotherapeuticpotential |